153863-35-5

Usage

Chemical Properties

White solid

InChI:InChI=1/C11H12N2O/c1-9-10(8-14)7-12-13(9)11-5-3-2-4-6-11/h2-7,14H,8H2,1H3

Upstream product

• 89193-16-8 ethyl 5-methyl-1-phenyl-1H-pyrazole-4-carboxylate 
• 7189-01-7 methyl 5-methyl-1-phenyl-1H-pyrazole-4-carboxylate 
• 100-63-0 phenylhydrazine 
• 59-88-1 phenylhydrazine hydrochloride 

Downstream Products

• 153863-65-1 4-Bromomethyl-5-methyl-1-phenyl-1H-pyrazole 
• 98700-50-6 5-Methyl-1-phenyl-1H-pyrazole-4-carbaldehyde 
• 193747-18-1 (5-Methyl-1-phenyl-1H-pyrazol-4-yl)-phenyl-methanol 
• 153863-61-7 4,5-dimethyl-1-phenyl-1H-pyrazole-3-carboxylic acid 
• 153863-52-6 4,5-dimethyl-1-phenyl-1H-pyrazole-3-carbonitrile 
• 1204423-69-7 Ethyl 2-fluoro-3-(5-methyl-1-phenylpyrazol-4-yl)propionate 
• 1204423-67-5 ethyl 2-fluoro-3-(5-methyl-1-phenylpyrazol-4-yl)acrylate 
• 1204423-71-1 C₁₃H₁₃FN₂O₂ 

Relevant academic research and scientific papers

ANDROGEN RECEPTOR ANTAGONISTS

Compounds that inhibit the androgen receptor, pharmaceutical compositions comprising one or more of the compounds, as well as methods of treating cancer using such compounds are described.

NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND

The present invention provides a compound having excellent regulating action on blood lipid level. The present invention provides a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof, etc., wherein A represents a 5-membered nitrogen-containing aromatic heterocyclyl group; R1 represents COOH or the like; each R2 represents an alkyl or the like; each R3 represents an optionally substituted phenyl, an optionally substituted phenylalkyl, or the like; m represents 0, 1, 2, or 3; n represents 0 or 1; each of R4, R5, R6, and R7 represents H, an alkyl, or the like; and B represents an optionally substituted naphthyl, an optionally substituted aromatic heterocyclyl, or a group represented by the following formula (II) wherein each of B1 and B2 represents an optionally substituted phenyl or an optionally substituted aromatic heterocyclyl.

1,6 - SUBSTITUTED (3R,6R) -3- (2,3-DIHYDRO-1H-INDEN-2-YL)-2,5-PIPERAZINEDIONE DERIVATIVES AS OXYTOCIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PRE-TERM LABOUR, DYSMENORRHEA AND ENDOMETRIOSIS

The present invention relates to compound S of Formula (I).

NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARγ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the same as an active agent.